Back To Schedule
Friday, September 11 • 7:30am - 9:15am
ISS: Cognitive Impairment Associated with Schizophrenia: Targeting Symptoms to Improve Patient Outcomes

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Join Dr. Maletic and Dr. McEvoy as they discuss the latest evidence on investigational therapies for cognitive impairment associated with schizophrenia. An in-depth review of developing insights into the pathophysiology and neurobiology of schizophrenia and potential targets for cognitive enhancement will be discussed, as well as the importance of employing validated measurement tools to better identify treatment gaps in symptom domains, cognitive functioning, and medication adherence to maximize quality of life and maintain recovery.

Psychopharmacology Credit: 1.25

This activity is supported by an educational grant from FORUM Pharmaceuticals.

avatar for Joseph McEvoy, MD

Joseph McEvoy, MD

Professor of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina; Staff Psychiatrist, Central Regional Hospital, Butler, North CarolinaJoseph P. McEvoy, MD, currently holds the Case Distinguished Chair in Psychotic Disorders at the Medical College... Read More →

Steering Committee
avatar for Vladimir Maletic, MD, MS

Vladimir Maletic, MD, MS

Clinical Professor of Neuropsychiatry and Behavioral Science, University of South Carolina School of Medicine, Columbia, South Carolina; Consulting Associate, Division of Child and Adolescent Psychiatry, Department of Psychiatry, Duke University, Durham, North CarolinaDr. Vladimir... Read More →

Friday September 11, 2015 7:30am - 9:15am PDT

Attendees (0)